Clinical Trial: AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction
Brief Summary: To test the AggreGuide A-100 AA Assay's effectiveness for detecting aspirin induced platelet dysfunction.
Detailed Summary:
Sponsor: Aggredyne, Inc.
Current Primary Outcome: Platelet Activity Index (PAI) before and after ingestion of aspirin [ Time Frame: 2 - 30 hours post aspirin ingestion ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Aggredyne, Inc.
Dates:
Date Received: July 30, 2013
Date Started: April 2013
Date Completion:
Last Updated: August 1, 2013
Last Verified: August 2013